$ZS

UBS Adjusts Price Target on Zscaler to $250 From $225, Keeps Buy Rating

UBS raised its price target for Zscaler (ZS) to $250 from $225, maintaining a Buy rating. The stock is currently trading at $213.07, up 0.39% on the day and 7.01% over the year. Wedbush recently lowered its target to $215 from $220, keeping an Outperform rating.

Original reporting
Published Oct 7, 2026, 1:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 1:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ZS
Bullish
high confidence
Mentioned
$ZS
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ZSBullishMed
01

Why it matters

The upgrade may prompt short-term buying, but the effect depends on broader market sentiment.

02

Market read

Analyst target changes can move mid‑cap tech stocks; Zscaler may see modest upside.

03

What to watch

Potential competitive pressure from larger cloud security players.

Relevance 6/10Novelty 6/10Timing: pre-market today

Background

UBS issued a revised price target for Zscaler, reflecting a more optimistic earnings outlook.

Company-level read

Ticker impact

$ZSBullishHigh confidence
Context

UBS raised Zscaler's price target to $250 from $225, maintaining a Buy rating.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target reflects UBS's improved valuation outlook, which can attract buying interest.

Market effects

May lift sentiment in the cybersecurity sector.

U.S. tech stocks could see modest gains.

Limited to investors tracking analyst upgrades.

Counterpoint

The target raise could be premature if market conditions tighten.

Key entities

  • Zscaler, Inc.

    Cybersecurity firm receiving a higher price target.

  • UBS

    Investment bank that raised the target.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.